Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Cindy Zhu"'
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-21 (2022)
Abstract Background Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma in adults. Metabolic reprogramming in tumors is closely related to the immune microenvironment. This study aimed to explore the interactions between metabolism-asso
Externí odkaz:
https://doaj.org/article/d3edb26cdd254a5b9fe990abfdde325e
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase expressed at early stages of normal development and in various cancers including ALK-positive anaplastic large cell lymphoma (ALK+ ALCL), in which it is the main therapeutic target. ALK t
Externí odkaz:
https://doaj.org/article/10b4a87fa2bd47a5a57d14ca338b0d13
Publikováno v:
Environmental Science and Pollution Research. 30:33432-33437
To study the association between environmental phenols exposure, including benzophenone-3 (BP3) and triclosan, and all-cause mortality and cancer mortality in adults. A total of 8035 participants were included from the National Health and Nutrition E
Autor:
Negin Jalali Motlagh, Jenny J. Linnoila, Enrico G Kullenberg, Stephan Schmidt, Cindy Zhu, Cindy Chau, Zhenwei Yao, Jing Wang, John W. Chen, Radha P. Narsimhan, Gregory R. Wojtkiewicz, Cuihua Wang
Publikováno v:
Proc Natl Acad Sci U S A
Inflammation drives the pathology of many neurological diseases. d-mannose has been found to exert an antiinflammatory effect in peripheral diseases, but its effects on neuroinflammation and inflammatory cells in the central nervous system have not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e00c0b5ea16ce5627261020e567fe12
https://europepmc.org/articles/PMC8673064/
https://europepmc.org/articles/PMC8673064/
Autor:
Chui Man Carmen Hui, Santosh K. Padala, Michael Lavelle, Mikhail T. Torosoff, Xinjun Cindy Zhu, Mandeep S. Sidhu
Publikováno v:
Case Reports in Cardiology, Vol 2015 (2015)
We report a case of an 83-year-old man with history of coronary artery disease and gastroesophageal reflux disease (GERD) who presented with sudden onset nocturnal dyspnea. He was diagnosed with non-ST elevation myocardial infarction based on the ele
Externí odkaz:
https://doaj.org/article/e15bae12fd6c48e385c75204df37b99f
Autor:
Xinjun Cindy Zhu, Matthew A. Adamo, Joseph E. Mazurkiewicz, Ramkumar Mathur, Mahabub Maraj Alam, Xiao-Feng Zhao, Yuan Liao, Yunfei Huang, Paul J. Feustel
Publikováno v:
J Neurosci
Excessive activation of mammalian target of rapamycin (mTOR) signaling is epileptogenic in genetic epilepsy. However, the exact role of microglial mTOR in acquired epilepsy remains to be clarified. In the present study, we found that mTOR is strongly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96da5a52a3209ad17fded8aba9a6e243
https://europepmc.org/articles/PMC7531547/
https://europepmc.org/articles/PMC7531547/
Autor:
Motohide Uemura, Cristina Suarez, Howard Gurney, Elisabeth Piault-Louis, David F. McDermott, Elaine T. Lam, Caroleen Quach, Christina Schiff, Stéphane Oudard, Sergio Bracarda, Bernard Escudier, Qian Cindy Zhu, Carsten Grüllich, Robert J. Motzer, Beiying Ding, Frede Donskov, Michael B. Atkins, Brian I. Rini, Susheela Carroll, Walter M. Stadler, Thomas Powles
Publikováno v:
Atkins, M B, Rini, B I, Motzer, R J, Powles, T, McDermott, D F, Suarez, C, Bracarda, S, Stadler, W M, Donskov, F, Gurney, H, Oudard, S, Uemura, M, Lam, E T, Grüllich, C, Quach, C, Carroll, S, Ding, B, Zhu, Q C, Piault-Louis, E, Schiff, C & Escudier, B 2020, ' Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma ', Clinical Cancer Research, vol. 26, no. 11, pp. 2506-2514 . https://doi.org/10.1158/1078-0432.CCR-19-2838
Purpose: Patient-reported outcomes (PRO) were evaluated in the phase III IMmotion151 trial (NCT02420821) to inform overall treatment/disease burden of atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f97b77f41738e00c8827f89a7e2cea
https://pure.au.dk/portal/da/publications/patientreported-outcomes-from-the-phase-iii-randomized-immotion151-trial(0e8fcf48-68ed-46f8-903a-fd0d93d00297).html
https://pure.au.dk/portal/da/publications/patientreported-outcomes-from-the-phase-iii-randomized-immotion151-trial(0e8fcf48-68ed-46f8-903a-fd0d93d00297).html
Autor:
Bo Shen, Yan Chen, Song Xu, Francis A. Farraye, Charles N. Bernstein, Marietta Iacucci, Garrett Lawlor, Joseph Picoraro, Xinjun Cindy Zhu, Ravi P. Kiran
Publikováno v:
SSRN Electronic Journal.
Background: Patients with inflammatory bowel disease (IBD) are susceptible to viral infection, which may include SARS-CoV-2 The management of IBD and COVID-19
Autor:
Jing Wang, Motlagh, Negin Jalali, Cuihua Wang, Wojtkiewicz, Gregory R., Schmidt, Stephan, Chau, Cindy, Narsimhan, Radha, Kuellenberg, Enrico G., Cindy Zhu, Linnoila, Jenny, Zhenwei Yao, Chen, John W.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 11/2/2021, Vol. 118 Issue 44, p1-8, 8p
Autor:
Michael B, Atkins, Brian I, Rini, Robert J, Motzer, Thomas, Powles, David F, McDermott, Cristina, Suarez, Sergio, Bracarda, Walter M, Stadler, Frede, Donskov, Howard, Gurney, Stephane, Oudard, Motohide, Uemura, Elaine T, Lam, Carsten, Grüllich, Caroleen, Quach, Susheela, Carroll, Beiying, Ding, Qian Cindy, Zhu, Elisabeth, Piault-Louis, Christina, Schiff, Bernard, Escudier
Publikováno v:
Clin Cancer Res
Patient-reported outcomes (PRO) were evaluated in the phase III IMmotion151 trial (NCT02420821) to inform overall treatment/disease burden of atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell c